Recently, President Donald Trump signed an executive order reclassifying cannabis as a Schedule 3 drug in the U.S., easing access to banking and enabling standard tax deductions for cannabis ...

Tilray’s (TLRY) aggressive expansion into Germany’s medical cannabis scene signals a drive to claim more of the global spotlight. The company posted fiscal 2025 highlights that include $821 million in ...

Cannabis stocks rose sharply Thursday on anticipation that President Donald Trump will sign an executive order to reschedule marijuana as a lower-class drug. Trump’s schedule showed he will sign an ...

This week's earnings calendar features a mix of early reports in the cannabis, AI infrastructure and consumer goods sectors.

Green Thumb, Tilray, and Trulieve will be helped by rescheduling marijuana, but investors should also consider other factors.

NEUMÜNSTER, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (TLRY), and a global leader in medical cannabis, empowering the therapeutic alliance ...

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Many cannabis stocks have experienced significant growth over the past six months. For instance, shares of Tilray Brands ( ...

SYDNEY, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between ...

The MarketWatch News Department was not involved in the creation of this content. NEUMÜNSTER, Germany, May 22, 2025 (GLOBE NEWSWIRE) -- Tilray Medical ("Tilray"), a division of Tilray Brands, Inc.

Tilray Medical has launched its cannabis brand Good Supply in Germany, aiming to provide affordable and high-quality medical cannabis options for patients. Good Supply, a well-regarded Canadian brand, ...